Schedule 13G ownership disclosure
Silence Therapeutics plc
Security class unavailable · CUSIP: G8128Y157
Event date: 2020-12-31
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 8.5000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001564590-21-006355
- Form type
- SC 13G
- Filer
- Quested Robert
- CIK
- CIK 1846454
- Filed
- Feb 17, 2021
- Reporting period
- Dec 31, 2020
- Description
- Schedule 13G beneficial ownership